(24 days)
The SpeedLock Knotless Fixation Device is indicated for use in fixation of soft tissue to bone.
Examples of such procedures include:
Shoulder: Bankart Repair, SLAP lesion repair, acromio-clavicular separation, rotator cuff repair, capsule shift/capsule-labral reconstruction, biceps tenodesis, and deltoid repair
Ankle: Lateral instability, medial instability, Achilles tendon repair/reconstruction, and midfoot reconstruction
Foot: Hallux valgus reconstruction
Elbow: Tennis elbow repair, biceps tendon reattachment
Knee: Extra-capsular repairs; reattachment of: medial collateral ligament, posterior oblique ligament or joint capsule closure to anterior proximal tibia; extra capsular reconstruction, ITB tenodesis; patellar ligament and tendon avulsions
The SpeedLock Knotless Fixation System is an implantable bone anchor with inserter handle designed for use in arthroscopic and orthopedic procedures. The SpeedLock is a knotless fixation device, meaning that manually tying surgical knots is not necessary for the fixation of suture to tissue.
The SpeedLock Knotless Fixation System consists of two primary parts: an implantable bone anchor and an anchor inserter, which is preloaded with the anchor. The anchor inserter is a disposable tool.
The entire product is packaged in a tray with a Tyvek® Iid, and the finished product is sterilized by ethylene oxide. Both the anchor and inserter are designed for single use only.
Here's an analysis of the provided information regarding the SpeedLock Knotless Fixation System's acceptance criteria and studies:
Context: The provided document is a 510(k) premarket notification from the FDA, along with the applicant's 510(k) Summary. This means the device is seeking clearance based on substantial equivalence to a legally marketed predicate device, rather than requiring a full demonstration of safety and effectiveness through extensive clinical trials as would be required for a PMA (Premarket Approval) device. Therefore, the "acceptance criteria" and "studies" will primarily revolve around demonstrating this substantial equivalence through non-clinical (bench) testing.
Description of Acceptance Criteria and the Study that Proves the Device Meets Them:
The SpeedLock Knotless Fixation System is a Class II medical device, and its clearance is based on demonstrating substantial equivalence to a previously cleared predicate device (SpeedLock Knotless Fixation System, K130196). The acceptance criteria for this type of submission are primarily met through performance testing that shows the new device functions similarly and meets safety specifications comparable to the predicate.
1. Table of Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria (Implicit from Submission) | Reported Device Performance and Study Findings |
|---|---|
| Mechanical Performance: Comparable static and cyclic fatigue strength to predicate device when anchored in simulated bone. (Based on FDA Guidance Document, Testing Bone Anchors, April 1996) | Bench Testing: Performed on both the proposed and predicate devices. Involved insertion of anchors into a simulated human bone substrate. Followed by both static and cyclic fatigue testing. The test results demonstrate that the proposed SpeedLock meets its design, performance, and safety specifications and that its mechanical properties are substantially equivalent to the predicate device. |
| Biocompatibility: Materials chosen for the implantable component must be biocompatible. (Implied by use of PEEK Optima LT3, a commonly accepted biomaterial for such applications) | Material Comparison: Predicate device uses Invibio PEEK Optima® LT1. Proposed device uses Invibio PEEK Optima® LT3. (Both are forms of PEEK, suggesting a material family known for biocompatibility. No specific biocompatibility study is detailed beyond the material change). |
| Sterility: Device must be supplied sterile. | Sterilization Method: Sterilized by ethylene oxide (EtO), matching the predicate device. (Implies validation of the sterilization process was performed, though not detailed). |
| Design Verification: Design outputs meet design inputs. | Design Verification Testing: Performed to verify design outputs met design inputs. The summary states the tests demonstrate the device meets design specifications. |
| Simulated Use Performance: Safety and effectiveness affirmed during simulated use for the device and accessory devices. | Simulated Use Testing: Performed on the device and accessory devices promoted for use with the SpeedLock system. Affirmed safety and effectiveness. |
| Intended Use / Indications: Must be comparable to the predicate device. | Comparison: The intended use and indications for use are identical to the predicate device. |
| Technological Characteristics: Comparable operating principle, design technology, delivery method, and other characteristics to the predicate device. | Comparison Chart: Numerous characteristics (e.g., delivery method, suture material, anchor material, design technology, suture locking mechanism, anchor diameter, depth of barb, deployed length, insertion method) were found to be either "Same" or very similar (e.g., PEEK LT1 vs LT3) to the predicate device. The summary explicitly states "minor differences between the proposed SpeedLock and predicate device do not raise any new questions of safety or effectiveness." |
2. Sample Size Used for the Test Set and Data Provenance:
- Sample Size: Not explicitly stated in the provided text for the bench testing. The document mentions "bench testing was performed on both the proposed and predicate devices" and "this in vitro testing involved insertion of the anchors into a simulated human bone substrate followed by both static and cyclic fatigue testing." While not a specific number, it indicates comparative testing was done.
- Data Provenance: The testing was retrospective in the sense that it was conducted after the device design was finalized to demonstrate its performance against the set criteria. The tests were performed as part of the regulatory submission process by ArthroCare Corporation. There is no mention of country of origin for the "data" as it's mechanical test data, not patient data.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
- This question is not applicable (N/A) in this context. The "test set" here refers to the mechanical bench testing of the device itself, not a diagnostic or AI-driven system requiring expert ground truthing of patient data. The "ground truth" for mechanical testing is established by engineering specifications, relevant ASTM/ISO standards, and the performance of the predicate device. The experts involved would be engineers and quality control personnel, ensuring the tests are conducted correctly and the results interpreted against the established performance criteria.
4. Adjudication Method for the Test Set:
- This question is not applicable (N/A) for mechanical bench testing. Adjudication methods like "2+1" or "3+1" are used for clinical studies involving multiple human readers assessing data (e.g., images), where an ultimate decision on a case (ground truth) needs to be reached by consensus or a tie-breaker. For mechanical testing, the "results" are quantitative measurements (e.g., force, displacement, cycles to failure) directly obtained from instruments. The "adjudication" is against pre-defined performance thresholds or comparison to the predicate device's performance.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance:
- No MRMC study was done, nor were any clinical studies. The submission explicitly states "No clinical or animal data are included in this submission." This device is a surgical fixation system, not a diagnostic or interpretative AI tool that would involve human readers.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:
- No standalone (algorithm-only) performance study was done. This device is a physical surgical implant, not a software algorithm.
7. The Type of Ground Truth Used:
- The "ground truth" for the device's performance in this context is established through a combination of:
- Engineering Specifications: Internal design requirements for the device's mechanical strength, fatigue life, and other performance characteristics.
- Predicate Device Performance: The established performance of the legally marketed predicate device (K130196) serves as a benchmark for substantial equivalence.
- FDA Guidance Document: The "FDA Guidance Document, Testing Bone Anchors, April 1996" provides recommendations for the types of tests (static and cyclic fatigue) and methodologies considered appropriate for evaluating such devices.
- Simulated Use Conditions: Performance during simulated surgical procedures.
8. The Sample Size for the Training Set:
- This question is not applicable (N/A). There is no "training set" as this is a physical medical device submission, not an AI/machine learning algorithm that requires training data.
9. How the Ground Truth for the Training Set Was Established:
- This question is not applicable (N/A), as there is no training set for this type of device.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three faces in profile, stacked on top of each other, representing the department's focus on people and health.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 11, 2015
ArthroCare Corporation Ms. Laura Kasperowicz Principal RA Specialist 15285 Alton Parkway, Suite 200 Irvine, California 92618
Re: K153313
Trade/Device Name: SpeedLock Knotless Fixation System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: Class II Product Code: MBI Dated: November 16, 2015 Received: November 17, 2015
Dear Ms. Kasperowicz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
{1}------------------------------------------------
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
| DEPARTMENT OF HEALTH AND HUMAN SERVICESFood and Drug Administration | |
|---|---|
| Indications for Use | Form Approved: OMB No. 0910-0120Expiration Date: January 31, 2017See PRA Statement below. |
| 510(k) Number (if known) | K153313 |
| Device Name | SpeedLock Knotless Fixation System |
| Indications for Use (Describe) | The SpeedLock Knotless Fixation Device is indicated for use in fixation of soft tissue to bone. |
| Examples of such procedures include: | Shoulder: Bankart Repair, SLAP lesion repair, acromio-clavicular separation, rotator cuff repair, capsule shift/capsule-labral reconstruction, biceps tenodesis, and deltoid repair |
| Ankle: Lateral instability, medial instability, Achilles tendon repair/reconstruction, and midfoot reconstruction | |
| Foot: Hallux valgus reconstruction | |
| Elbow: Tennis elbow repair, biceps tendon reattachment | |
| Knee: Extra-capsular repairs; reattachment of: medial collateral ligament, posterior oblique ligament or joint capsule closure to anterior proximal tibia; extra capsular reconstruction, ITB tenodesis; patellar ligament and tendon avulsions | |
| Type of Use (Select one or both, as applicable) | Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
| FORM FDA 3881 (8/14) | Page 1 of 1 | |
|---|---|---|
| ---------------------- | -- | ------------- |
PSC Publishing Services (301) 443-6740 EF
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for ArthroCare. The logo consists of a stylized, circular graphic on the left and the word "ArthroCare" in a sans-serif font on the right. The graphic is made up of several curved lines in a dark red color, arranged to create a sense of motion or rotation. The text "ArthroCare" is in a dark gray color, and there is a registered trademark symbol next to the word "Care".
510(k) Summary
ArthroCare® Corporation
SpeedLock® Knotless Fixation System
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
General Information
| Submitter Name: | ArthroCare Corporation, a Smith & Nephew Company |
|---|---|
| Address | 15285 Alton Parkway, Suite 200Irvine, CA. 92618 |
| Contact Person: | Laura KasperowiczPrinciple Regulatory Affairs SpecialistPhone: 949-585-2406Fax: 949-585-2401 |
| Date Prepared: | November 16, 2015 |
Device Name
SpeedLock® Knotless Fixation System Proprietary Name:
| Common Name: | Bone Anchor |
|---|---|
| Classification Name: | Smooth or threaded metallic bone fixation fastener |
| Device Class: | Class II |
| Product Code: | MBI |
| CFR Section: | 21 CFR 888.3040 |
Predicate Device
SpeedLock® Knotless Fixation System: K130196 (cleared February 27, 2013)
Description
The SpeedLock Knotless Fixation System is an implantable bone anchor with inserter handle designed for use in arthroscopic and orthopedic procedures. The SpeedLock is a knotless fixation device, meaning that manually tying surgical knots is not necessary for the fixation of suture to tissue.
The SpeedLock Knotless Fixation System consists of two primary parts: an implantable bone anchor and an anchor inserter, which is preloaded with the anchor. The anchor inserter is a disposable tool.
The entire product is packaged in a tray with a Tyvek® Iid, and the finished product is sterilized by ethylene oxide. Both the anchor and inserter are designed for single use only.
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image contains the logo for ArthroCare. The logo consists of a circular graphic on the left and the word "ArthroCare" on the right. The circular graphic is made up of several curved lines in a maroon color. The word "ArthroCare" is written in a sans-serif font in a dark gray color, with the registered trademark symbol next to it.
Intended Use/Indications For Use
The SpeedLock Knotless Fixation Device is indicated for use in fixation of soft tissue to bone.
Examples of such procedures include:
Shoulder: Bankart Repair, SLAP lesion repair, acromio-clavicular separation, rotator cuff repair, capsule shift/capsule-labral reconstruction, biceps tenodesis, and deltoid repair
Ankle: Lateral instability, medial instability, Achilles tendon repair/reconstruction, and midfoot reconstruction
Foot: Hallux valgus reconstruction
Elbow: Tennis elbow repair, biceps tendon reattachment
Knee: Extra-capsular repairs; reattachment of: medial collateral ligament, posterior oblique ligament or joint capsule closure to anterior proximal tibia; extra capsular reconstruction, ITB tenodesis; patellar ligament and tendon avulsions
Non-Clinical Data
Bench testing was performed on both the proposed and predicate devices in accordance with the FDA Guidance Document, Testing Bone Anchors, April 1996. This in vitro testing involved insertion of the anchors into a simulated human bone substrate followed by both static and cyclic fatigue testing. Design Verification testing was performed in order to verify the design outputs meet the design inputs. Simulated use testing was performed on the device and accessory devices which will be promoted for use with the SpeedLock system in order to affirm safety and effectiveness.
The test results demonstrate that the proposed SpeedLock meets its design, performance, and safety specifications. Based on the test results, the proposed device performs as intended and mechanical properties are substantially equivalent to the predicate device when used in accordance with labeling.
Clinical Data
No clinical or animal data are included in this submission.
Summary
All testing demonstrates that the proposed SpeedLock performs as intended and mechanical properties are substantially equivalent when used in accordance with the labeling.
As the intended use, operating principle, materials and technological characteristics are comparable to the predicate device, the proposed SpeedLock Knotless Fixation System is substantially equivalent. The minor differences between the proposed SpeedLock and predicate device do not raise any new questions of safety or effectiveness.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for ArthroCare. The logo consists of a circular design on the left, made up of several curved red lines. To the right of the design is the company name, "ArthroCare," in a dark gray, sans-serif font. A registered trademark symbol is present to the upper right of the word "Care."
| Comparison of Technological Characteristics | ||
|---|---|---|
| Characteristics | Predicate DeviceSpeedLock(K130196) | Proposed DeviceSpeedLock |
| Intended Use | Fixation of soft tissue to bone | Same |
| Delivery Method | Arthroscopic and Limited Access | Same |
| How Supplied | Sterile (EtO) | Same |
| Suture Material | #2 UHMWPE MagnumWire® Suture | Same |
| Anchor Material | Invibio PEEK Optima® LT1 | Invibio PEEK Optima® LT3 |
| Design Technology | Anchor with 9 radial barbs (interference fit) | Same |
| Suture Locking Mechanism | Plug/Cylinder Compression | Same |
| Diameter of Anchor Body | 3.0 - 3.5 mm | Same |
| Surface of Cortical Lock | 1.25 cm² | Same |
| Depth of Barb | 0.25 mm | Same |
| Anchor Deployed Length | 12 - 13 mm | Same |
| Method of Anchor Insertion | Inserted into a drilled hole | Same |
| Accessory DevicesPromoted for use with theSpeedLock System | 3.0mm Tapered Twist Drill, 3.0mm+Tapered Twist Drill, 3.5mm High VisibilityDrill Guide, 3.5mm Low Profile DrillGuide, Sharp Tipped Obturator, PathFinder®Obturator | Same and SpeedStitch® Suture Passer |
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.